GlassScriptPhysician profile
Edward Gronet
NPI 1457741753
$28,136.77
in general payments reported to CMS, 2019-2025
30 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,760 · 2020: $1,313 · 2021: $15K · 2022: $2,828 · 2023: $1,448 · 2024: $3,869 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,857 · Travel and Lodging: $1,500 · Consulting Fee: $1,000 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,857.27 |
| Travel and Lodging | $1,500.00 |
| Consulting Fee | $1,000.00 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $10,837.73 | 2019-2023 | |
| Motiva USA, LLC | $3,176.38 | 2024-2025 | |
| Allergan, INC. | $3,029.85 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,737.43 | 2019-2024 | |
| Davol INC. | $1,362.49 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip |
| Mentor Worldwide LLC | $1,321.92 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $1,099.01 | 2023-2025 | |
| Integra Lifesciences Corporation | $729.58 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $649.13 | 2021 | |
| Kerecis Limited | $593.73 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $525.13 | 2019 | |
| Polynovo North America LLC | $523.62 | 2019-2022 | |
| Sientra, INC. | $397.51 | 2021-2022 | |
| Organogenesis INC. | $258.90 | 2021-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $249.56 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $222.45 | 2019 | |
| Tela Bio, INC. | $217.18 | 2021-2022 | |
| Portola Pharmaceuticals, LLC | $210.30 | 2019 | |
| Acera Surgical, INC. | $197.46 | 2020-2022 | |
| Innovation Technologies INC | $138.53 | 2021 | |
| Alexion Pharmaceuticals, INC. | $124.69 | 2021 | |
| Misonix INC | $121.44 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $121.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $119.78 | 2019 | |
| Revance Therapeutics, INC. | $52.03 | 2024 | Daxxify |
| Smith+Nephew, INC. | $27.79 | 2019-2021 | |
| Urgo Medical North America, LLC | $26.89 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Access Pro Medical, LLC | $26.86 | 2023 | Matriderm |
| Janssen Pharmaceuticals, INC | $21.33 | 2019 | |
| Galderma Laboratories, L.P. | $16.94 | 2024 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Gronet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.